CHO Pharma, Inc. (6586.TWO)
TWD 45.15
(4.76%)
TWD 45.15
(4.76%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 3.08 Billion TWD | 92.61% |
| 2022 | 1.6 Billion TWD | -15.39% |
| 2021 | 1.89 Billion TWD | -11.63% |
| 2020 | 2.14 Billion TWD | -11.64% |
| 2019 | 2.42 Billion TWD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 3.01 Billion TWD | 0.0% |
| 2024 Q1 | 3.01 Billion TWD | -2.42% |
| 2023 Q4 | 3.08 Billion TWD | 0.0% |
| 2023 FY | 3.08 Billion TWD | 92.61% |
| 2023 Q2 | 1.43 Billion TWD | 0.0% |
| 2023 Q1 | 1.43 Billion TWD | -10.41% |
| 2023 Q3 | 3.08 Billion TWD | 114.99% |
| 2022 Q3 | 1.6 Billion TWD | 0.0% |
| 2022 FY | 1.6 Billion TWD | -15.39% |
| 2022 Q4 | 1.6 Billion TWD | 0.0% |
| 2021 FY | 1.89 Billion TWD | -11.63% |
| 2020 FY | 2.14 Billion TWD | -11.64% |
| 2019 FY | - TWD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| SYN-TECH Chem. & Pharm. Co., Ltd. | 2.9 Billion TWD | -6.382% |
| Level Biotechnology Inc. | 822.67 Million TWD | -275.122% |
| Sagittarius Life Science Corp | 664.72 Million TWD | -364.258% |
| NeoCore Technology Co., Ltd. | 548.74 Million TWD | -462.377% |
| GeneReach Biotechnology Corp. | 1.17 Billion TWD | -162.386% |
| Genomics BioSci & Tech. Co.,Ltd. | 1.13 Billion TWD | -172.174% |
| Visgeneer Inc. | 397.17 Million TWD | -676.993% |
| Sunmax Biotechnology Co., Ltd. | 2.15 Billion TWD | -42.936% |
| G&E Herbal Biotechnology Co., Ltd. | 883.09 Million TWD | -249.456% |
| Neith Corporation | 192.15 Million TWD | -1506.028% |
| TaiwanJ Pharmaceuticals Co., Ltd. | 73.55 Million TWD | -4095.371% |
| Enimmune corporation | 604.82 Million TWD | -410.234% |
| TaiRx, Inc. | 833.74 Million TWD | -270.14% |
| EirGenix Inc. | 11.16 Billion TWD | 72.354% |
| BioLASCO Taiwan Co., Ltd. | 573.13 Million TWD | -438.444% |
| Sunny Pharmtech Inc. | 1.71 Billion TWD | -80.221% |
| Advagene Biopharma Co., Ltd. | 147.93 Million TWD | -1986.086% |
| BioGend Therapeutics Co., Ltd. | 1.05 Billion TWD | -193.773% |
| Feng Chi Biotech Corp. | 301.03 Million TWD | -925.15% |
| Lukas Biomedical Inc. | 441.19 Million TWD | -599.477% |
| RBC Bioscience Corporation | 753.79 Million TWD | -309.402% |
| BiOptic Inc. | 613.77 Million TWD | -402.797% |
| Anti-Microbial Savior BioteQ Co., Ltd | 128.04 Million TWD | -2310.077% |
| Shine-On BioMedical Co.,Ltd. | 1.15 Billion TWD | -166.103% |
| Great Novel Therapeutics Biotech & Medicals | 644.84 Million TWD | -378.566% |
| Syngen Biotech Co.,Ltd. | 3.1 Billion TWD | 0.651% |
| Mycenax Biotech Inc. | 3.77 Billion TWD | 18.151% |
| Medigen Vaccine Biologics Corporation | 6.09 Billion TWD | 49.348% |
| Bio Preventive Medicine Corp. | 264.65 Million TWD | -1066.049% |
| TaiMed Biologics Inc. | 3.89 Billion TWD | 20.747% |
| GlycoNex Incorporation | 1.55 Billion TWD | -98.738% |
| Taiwan Advance Bio-Pharmaceutical Inc. | 748.57 Million TWD | -312.256% |
| SynCore Biotechnology Co.,Ltd | 378.36 Million TWD | -715.629% |
| Lin BioScience, Inc. | 3.59 Billion TWD | 14.199% |
| BRIM Biotechnology, Inc. | 1.77 Billion TWD | -73.502% |
| VBI | 452.1 Million TWD | -582.596% |
| NaviFUS Corp. | 490.53 Million TWD | -529.115% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | 1.22 Billion TWD | -151.774% |
| Sinew Pharma Inc. | 1.36 Billion TWD | -126.352% |
| Andros Pharmaceuticals Co.,Ltd | 529.14 Million TWD | -483.21% |
| Greenyn Biotechnology Co., Ltd | 1.16 Billion TWD | -165.719% |
| Lumosa Therapeutics Co., Ltd. | 1.65 Billion TWD | -86.323% |
| AP Biosciences Inc | 890.75 Million TWD | -246.451% |
| Medigen Biotechnology Corp. | 8.52 Billion TWD | 63.81% |
| 3D Global Biotech Inc. | 324.14 Million TWD | -852.044% |
| Pharmosa Biopharm Inc. | 1.33 Billion TWD | -131.399% |
| Intech Biopharm Corporation | 2.71 Billion TWD | -13.831% |
| Oneness Biotech Co., Ltd. | 15.36 Billion TWD | 79.913% |
| Eusol Biotech Co.,Ltd. | 410.25 Million TWD | -652.217% |
| TWi Biotechnology, Inc. | 396.85 Million TWD | -677.63% |
| Ever Supreme Bio Technology Co., Ltd | 2.07 Billion TWD | -48.658% |
| TCI GENE Inc. | 1.16 Billion TWD | -164.682% |
| MegaPro Biomedical Co., Ltd | 294.58 Million TWD | -947.6% |
| Senhwa Biosciences, Inc. | 1.36 Billion TWD | -126.36% |
| Taiwan Bio Therapeutics Co., Ltd | 941.76 Million TWD | -227.687% |
| NatureWise Biotech & Medicals Corporation | 698.45 Million TWD | -341.839% |
| PharmaEngine, Inc. | 3.95 Billion TWD | 21.95% |
| Savior Lifetec Corporation | 3.82 Billion TWD | 19.27% |
| TaiGen Biopharmaceuticals Holdings Limited | 1.22 Billion TWD | -150.93% |
| OBI Pharma, Inc. | 5.6 Billion TWD | 44.931% |
| Meribank Biotech Co., Ltd | 1.06 Billion TWD | -190.585% |
| Acepodia, Inc. | 6.81 Billion TWD | 54.74% |
| Caliway Biopharmaceuticals Co., Ltd. | 3.82 Billion TWD | 19.351% |